Professor Kirill Alexandrov obtained his Masters degree in Invertebrate Zoology at the Leningrad State University, Russia in 1989 and completed his PhD in Cell Biology at EMBL Heidelberg, Germany in 1995. He went on to postgraduate work at the Department of Physical Biochemistry at the Max-Planck Institute in Dortmund, Germany, and remained with the Institute for 12 years, becoming a group leader in 1999. In 2004, Professor Alexandrov was awarded Germany’s highest career development fellowship, the Heisenberg Award.
Professor Alexandrov co-founded the successful biotechnology company Jena Bioscience GMBH in 1998 and UK/Australian company Molecular Warehouse ltd in 2015. He is credited with establishing the Dortmund Protein Production Facility at the Max-Planck Institute in Dortmund, Germany.
He joined the Institute for Molecular Bioscience (IMB) and The Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland in 2008 as an ARC Future Fellow. He introduced high−throughput molecular cloning technology to the UQ Protein Expression Facility.
Professor Alexandrov has raised more than $22 million in funding since 2008, securing multiple Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC) grants. He holds six active patents all of which are either sold or licenced. Professor Alexandrov has received more than 30 invitations to speak at national and international conferences.